Gujarat to start production of drug substance used in manufacturing of Covaxin msn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from msn.com Daily Mail and Mail on Sunday newspapers.
Pact signed between Bharat Biotech, Gujarat Covid Vaccine Consortium: Hester Biosciences
SECTIONS
Last Updated: May 27, 2021, 10:25 PM IST
Share
Synopsis
GCVC comprises Gujarat Biotechnology Research Centre (GBRC), Hester Biosciences and Omnibrx Biotechnologies Pvt Ltd, Hester Biosciences said in a regulatory filing.
ANI
GCVC comprises Gujarat Biotechnology Research Centre (GBRC), Hester Biosciences and Omnibrx Biotechnologies Pvt Ltd, Hester Biosciences said in a regulatory filing.
Hester Biosciences on Thursday said a memorandum of understanding (MoU) has been signed between vaccine maker Bharat Biotech and Gujarat Covid Vaccine Consortium (GCVC) for contract manufacturing the drug substance for Covaxin.
GCVC comprises Gujarat Biotechnology Research Centre (GBRC), Hester Biosciences and Omnibrx Biotechnologies Pvt Ltd, Hester Biosciences said in a regulatory filing.
URL copied
Govt exploring possibility of Covaxin production outside India
To address the shortage of COVID-19 jabs in the country, the government is exploring the possibility of boosting production of vaccines, including identifying manufacturing sites for indigenously developed Covaxin outside India, sources said. The government also intends to take up the matter with the World Health Organisation (WHO) to step up Covaxin production.
It will also take up with Moderna, Johnson and Johnson and other vaccine makers the issue of granting voluntary licence to third-party manufacturers in India on transfer of technology basis.
These issues were discussed in an inter-ministerial meeting on May 18 to deliberate upon the options, including voluntary licence, compulsory licence and government use authorisation under the Patents Act, 1970, available to increase the availability of drugs and vaccines used for treatment of COVID-19.